Schedule 13D ownership disclosure
Aviragen Therapeutics Inc
Security class unavailable · CUSIP: 053761102
Event date: 2018-01-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.7400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-18-000159
- Form type
- SC 13D
- Filer
- Vaxart, Inc.
- CIK
- CIK 72444
- Filed
- Jan 18, 2018
- Reporting period
- Jan 16, 2018
- Description
- Schedule 13D beneficial ownership